Evidence map›Paper›PMID 33251117›Full record

ReviewJournal of clinical & translational endocrinology2020

An overview of Charcot's neuroarthropathy.

Dured Dardari

Registry-linked trialAbstract readReview
In one paragraph

Review in Journal of clinical & translational endocrinology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07139184 (Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus), which is not on this map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07139184 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Risk Factor Analysis for Charcot Foot in Patients With Diabetes Mellitus: The Interplay of Inflammatory Cytokines and Metabolic Factors

TypeobservationalSponsorAssiut UniversityRan2025 to 2027Enrolled60ConditionsCharcot FootArmsDiagnosis of Charcot foot disease, Hematologic and biochemical parameters,, ELIZA Assay
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Review
  4. Article
  5. Asymptomatic Charcot foot in longstanding diabetes.Surgery in practice and science · 2026
    Article
  6. Article
  7. [Imaging assessment and treatment of Charcot arthropathy of the shoulder assisted by NGH classification].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2026
    Review
  8. Article
  9. Article
  10. Burning Issues/Hot Topics: The Charcot Foot.Journal of clinical medicine · 2026
    Review
  11. Article
  12. Article
  13. Review
  14. [Diabetic Charcot neuroarthropathy initially misdiagnosed as rheumatoid arthritis and gout: A case report].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2025
    Article
  15. Non-Infectious Spinal Diseases Mimicking Infection: A Pictorial Essay.Journal of the Korean Society of Radiology · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Charcot spinal arthropathy: a case series.Spinal cord series and cases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Dured DardariDiabetology Department, Centre Hopitalier Sud Francilien, Corbeil Essonnes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Charcot's neuroarthropathy is a destructive complication of the joints, which is often found in people with diabetes with peripheral neuropathy. Despite the fact that its description was published almost 130 years ago, its pathophysiology, diagnosis, and treatment remain areas that need to be described. Thanks to the use of bone remodelling, new therapeutic classes have emerged, we hope that this review will shed light on the pathology from its discovery through to the current state of knowledge on its classification, diagnosis and treatment methods.

Indexed as

Charcot footCharcot neuroarthropathyCharcot osteoarthropathyCN, Charcot neuroarthropathyOAD, oral antidiabeticOPG, osteoprotegerinRANKL, receptor activator of nuclear factor-BT1DM, type 1 diabetes mellitusT2DM, type 2 diabetes mellitusTIND, treatment-induced neuropathy of diabetesType 1 diabetes mellitusType 2 diabetes mellitus

Identifiers

PMID33251117
PMCPMC7677697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.